These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

816 related articles for article (PubMed ID: 16775498)

  • 1. Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease.
    Konikoff MR; Denson LA
    Inflamm Bowel Dis; 2006 Jun; 12(6):524-34. PubMed ID: 16775498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low fecal calprotectin predicts sustained clinical remission in inflammatory bowel disease patients: a plea for deep remission.
    Mooiweer E; Severs M; Schipper ME; Fidder HH; Siersema PD; Laheij RJ; Oldenburg B
    J Crohns Colitis; 2015 Jan; 9(1):50-5. PubMed ID: 25518048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fecal calprotectin: its scope and utility in the management of inflammatory bowel disease.
    Ikhtaire S; Shajib MS; Reinisch W; Khan WI
    J Gastroenterol; 2016 May; 51(5):434-46. PubMed ID: 26897740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease.
    D'Haens G; Ferrante M; Vermeire S; Baert F; Noman M; Moortgat L; Geens P; Iwens D; Aerden I; Van Assche G; Van Olmen G; Rutgeerts P
    Inflamm Bowel Dis; 2012 Dec; 18(12):2218-24. PubMed ID: 22344983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fecal hemoglobin and calprotectin are equally effective in identifying patients with inflammatory bowel disease with active endoscopic inflammation.
    Mooiweer E; Fidder HH; Siersema PD; Laheij RJ; Oldenburg B
    Inflamm Bowel Dis; 2014 Feb; 20(2):307-14. PubMed ID: 24374878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colorectal inflammation is well predicted by fecal calprotectin in children with gastrointestinal symptoms.
    Fagerberg UL; Lööf L; Myrdal U; Hansson LO; Finkel Y
    J Pediatr Gastroenterol Nutr; 2005 Apr; 40(4):450-5. PubMed ID: 15795593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic performance of rapid tests for detection of fecal calprotectin and lactoferrin and their ability to discriminate inflammatory from irritable bowel syndrome.
    Otten CM; Kok L; Witteman BJ; Baumgarten R; Kampman E; Moons KG; de Wit NJ
    Clin Chem Lab Med; 2008; 46(9):1275-80. PubMed ID: 18597588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fecal calprotectin: validation as a noninvasive measure of bowel inflammation in childhood inflammatory bowel disease.
    Bunn SK; Bisset WM; Main MJ; Gray ES; Olson S; Golden BE
    J Pediatr Gastroenterol Nutr; 2001 Jul; 33(1):14-22. PubMed ID: 11479402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fecal S100A12 and fecal calprotectin as noninvasive markers for inflammatory bowel disease in children.
    Sidler MA; Leach ST; Day AS
    Inflamm Bowel Dis; 2008 Mar; 14(3):359-66. PubMed ID: 18050298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fecal Calprotectin in Inflammatory Bowel Disease].
    Lee J
    Korean J Gastroenterol; 2016 May; 67(5):233-7. PubMed ID: 27206433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fecal calprotectin levels in children is more tightly associated with histological than with macroscopic endoscopy findings.
    Hradsky O; Ohem J; Mitrova K; Durilova M; Kotalova R; Nevoral J; Kolho KL; Bronsky J
    Clin Lab; 2014; 60(12):1993-2000. PubMed ID: 25651733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of three commercial fecal calprotectin ELISA test kits used in patients with Inflammatory Bowel Disease.
    Mirsepasi-Lauridsen HC; Bachmann Holmetoft U; Ingdam Halkjær S; Angeliki Krogfelt K; Munk Petersen A
    Scand J Gastroenterol; 2016; 51(2):211-7. PubMed ID: 26359672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The utility of fecal calprotectin in predicting the need for escalation of therapy in inflammatory bowel disease.
    Kwapisz L; Gregor J; Chande N; Yan B; Ponich T; Mosli M
    Scand J Gastroenterol; 2017 Aug; 52(8):846-850. PubMed ID: 28423962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fecal neutrophil gelatinase-associated lipocalin as a biomarker for inflammatory bowel disease.
    Thorsvik S; Damås JK; Granlund AV; Flo TH; Bergh K; Østvik AE; Sandvik AK
    J Gastroenterol Hepatol; 2017 Jan; 32(1):128-135. PubMed ID: 27640344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fecal M2-pyruvate kinase (M2-PK): a novel marker of intestinal inflammation.
    Chung-Faye G; Hayee B; Maestranzi S; Donaldson N; Forgacs I; Sherwood R
    Inflamm Bowel Dis; 2007 Nov; 13(11):1374-8. PubMed ID: 17577247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fecal Calprotectin.
    Ayling RM; Kok K
    Adv Clin Chem; 2018; 87():161-190. PubMed ID: 30342711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of fecal calprotectin in the assessment of intestinal inflammation in children with familial Mediterranean fever.
    Gucenmez OA; Kume T; Makay B; Babayigit O; Arslan N; Unsal E
    Int J Rheum Dis; 2018 Oct; 21(10):1844-1848. PubMed ID: 30345692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Faecal calprotectin -- a useful tool in the management of inflammatory bowel disease.
    Burri E; Beglinger C
    Swiss Med Wkly; 2012; 142():w13557. PubMed ID: 22481443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Faecal calprotectin testing for differentiating amongst inflammatory and non-inflammatory bowel diseases: systematic review and economic evaluation.
    Waugh N; Cummins E; Royle P; Kandala NB; Shyangdan D; Arasaradnam R; Clar C; Johnston R
    Health Technol Assess; 2013 Nov; 17(55):xv-xix, 1-211. PubMed ID: 24286461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fecal calprotectin levels and serological responses to microbial antigens among children and adolescents with inflammatory bowel disease.
    Ashorn S; Honkanen T; Kolho KL; Ashorn M; Välineva T; Wei B; Braun J; Rantala I; Luukkaala T; Iltanen S
    Inflamm Bowel Dis; 2009 Feb; 15(2):199-205. PubMed ID: 18618670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.